NEWS Coverage

WANdisco Secures Three-year Contract with US Healthcare Company

December 28 2018

The AIM-listed company said on Thursday that the agreement will see IBM deploy its patented Big Data and Cloud product, WANdisco Fusion.

The agreement is valued at about $700k in royalties to be paid to WANdisco.

Earlier this year, the group significantly expanded its relationship with IBM, increasing the royalty percentage to 50% from 30% and agreeing a guaranteed annual royalty commitment. In addition, it has also engaged in joint engineering work to support IBM BigSQL and other products, expanding the total addressable market.

WANdisco said the healthcare client has "substantial" data requirements, with more than 45 million customers and 5,700 hospitals in its network. It is using Fusion on-premise for replication and disaster recovery. It is also the first sale of WANdisco's newly released Live backup solution.

Chief executive and chairman David Richards said: "We are continuing to gain strong traction in industries where critical data is needed to be continuously available. This is the second major healthcare deal we have agreed this month and follows our largest ever cloud deal valued at $3 million. Our pipeline with IBM continues to build and our expanded relationship means we can efficiently and profitably service on-premise contracts."

Read more



Get notified of the latest WANdisco Blog posts and Newsletter.

03rd - 03rd November 2021 | Webcast

Accelerate Your Move from Hadoop to Google Cloud Analytics

17th - 17th November 2021 | Webcast

Accelerate Your Move from Hadoop to Databricks Lakehouse

01st - 01st December 2021 | Webcast

Accelerate Your Move from Hadoop to Snowflake Cloud Analytics

Cookies and Privacy

At WANdisco, we respect your concerns about privacy and value the relationship that we have with you.

Like many companies, we use technology on our website to collect information that helps us enhance your experience and our products and services. The cookies that we use at WANdisco allow our website to work and help us to understand what information and advertising is most useful to visitors.

Please take a moment to familiarise yourself with our cookie practices and let us know if you have any questions by getting in touch through any of the methods listed on our "Contact Us" page.

We have tried to keep this Notice as simple as possible, but if you’re not familiar with terms, such as cookies, IP addresses, and browsers, then read about these key terms first.